Is QuiaPEG Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, QuiaPEG Pharmaceuticals pays dividends. Last time was Wednesday 5th of April 2017 where the investors holding the stock on Thursday 30th of March 2017 were paid SEK2.3915 per share. Over the last 6 times between 2012 and 2017, QuiaPEG Pharmaceuticals has paid SEK3.3263 with an average of SEK0.55 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for QuiaPEG Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK128.27, you would have made a loss of SEK-128.25 per share or -99.98%
No, the average daily trading liquidity for QuiaPEG Pharmaceuticals is SEK3.33 million. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
QuiaPEG Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for QuiaPEG Pharmaceuticals to be high [0.85 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.